Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 14;14(2):e22216.
doi: 10.7759/cureus.22216. eCollection 2022 Feb.

Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline

Daniel Ho  1 , Nicola A Clayton  2 , Bruce Silverstein  3 , Alan Koff  4
Affiliations
Case Reports

Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline

Daniel Ho et al. Cureus. .

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia may lead to endogenous endophthalmitis (EE), an uncommon disease process described mainly in case series and case reports. It is considered an ophthalmologic emergency requiring prompt diagnosis and treatment with systemic intravenous and intravitreal antibiotics to improve mortality and prevent blindness. The management of MRSA EE represents a challenge, as there are no established guidelines for treatment or outcomes. In our case report, we demonstrate that ceftaroline may be considered as an alternative option to treat MRSA EE in lieu of vancomycin due to drug-induced rash, given the promising penetration of the blood brain barrier and low minimum inhibitory concentration (MIC) values for most Staphylococcus aureus isolates.

Keywords: bacteremia; ceftaroline; endogenous endophthalmitis; methicillin resistant staphylococcus aureus (mrsa); vancomycin failure.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. A diffuse morbilliform exanthem attributed to vancomycin in our patient
See this image and copyright information in PMC

References

    1. Staphylococcus aureus bacteremia, risk factors, complications, and management. Keynan Y, Rubinstein E. Crit Care Clin. 2013;29:547–562. - PubMed
    1. Endogenous endophthalmitis in patients with MRSA septicemia: a case series and review of literature. Shenoy SB, Thotakura M, Kamath Y, Bekur R. Ocul Immunol Inflamm. 2016;24:515–520. - PubMed
    1. Off-label use of ceftaroline fosamil: a systematic review. Pani A, Colombo F, Agnelli F, Frantellizzi V, Baratta F, Pastori D, Scaglione F. Int J Antimicrob Agents. 2019;54:562–571. - PubMed
    1. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Brockhaus L, Goldblum D, Eggenschwiler L, Zimmerli S, Marzolini C. Clin Microbiol Infect. 2019;25:1364–1369. - PubMed
    1. Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant streptococcus pneumoniae in an experimental rabbit meningitis model. Cottagnoud P, Cottagnoud M, Acosta F, Stucki A. Antimicrob Agents Chemother. 2013;57:4653–4655. - PMC - PubMed

Publication types

LinkOut - more resources